Detalhe da pesquisa
1.
Prognostic indicators in pediatric clinically isolated syndrome.
Ann Neurol
; 81(5): 729-739, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28439957
2.
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.
Brain
; 138(Pt 11): 3275-86, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26362907
3.
Genetic burden of common variants in progressive and bout-onset multiple sclerosis.
Mult Scler
; 20(7): 802-11, 2014 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24277324
4.
A genome-wide association study in progressive multiple sclerosis.
Mult Scler
; 18(10): 1384-94, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22457343
5.
Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab.
Clin Exp Rheumatol
; 29(4 Suppl 67): S54-7, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21968237
6.
Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability.
J Neurol Sci
; 263(1-2): 15-9, 2007 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17673234
7.
The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.
PLoS One
; 11(6): e0157721, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27348606
8.
Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.
Clin Exp Rheumatol
; 28(4 Suppl 60): S102, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20868587
9.
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients.
PLoS One
; 10(3): e0120754, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25816303
10.
Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans.
Neurosci Lett
; 530(2): 155-60, 2012 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23069673